| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Aug 21, 2020 | Aug 24, 2020 | Vistagen Therapeutics, Inc. | Director | Buy | 91.3 | +30,000 | 129.03% | ✗ | $20.7K |
| Jun 10, 2019 | Jun 11, 2019 | DURECT CORP | Director | Buy | 91.3 | +25,000 | 16.36% | ✗ | $13.7K |
| May 24, 2019 | May 28, 2019 | DURECT CORP | Director | Buy | 91.3 | +30,000 | 24.43% | ✗ | $18.9K |
| May 13, 2019 | May 15, 2019 | DURECT CORP | Director | Buy | 85.0 | +9,600 | 8.48% | ✗ | $6.8K |
| May 13, 2019 | May 14, 2019 | DURECT CORP | Director | Buy | 91.3 | +40,400 | 89.78% | ✗ | $28.1K |
| Mar 13, 2019 | Mar 15, 2019 | DURECT CORP | Director | Buy | 85.0 | +3,700 | 5.35% | ✗ | $3K |
| Mar 13, 2019 | Mar 15, 2019 | DURECT CORP | Director | Buy | 91.3 | +21,300 | 106.50% | ✗ | $17.5K |
| Mar 13, 2019 | Mar 14, 2019 | Vistagen Therapeutics, Inc. | Director | Buy | 91.3 | +20,000 | 615.20% | ✗ | $25.3K |
| Dec 12, 2012 | Dec 14, 2012 | DURECT CORP | Director | Buy | 91.3 | +15,000 | 45.72% | ✗ | $13.6K |
| Aug 27, 2012 | Aug 29, 2012 | DURECT CORP | Director | Buy | 90.0 | +7,810 | 31.24% | ✗ | $7.6K |
| Aug 23, 2012 | Aug 27, 2012 | DURECT CORP | Director | Buy | 90.0 | +5,000 | 25.00% | ✗ | $5K |